TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Decentralized Clinical Trials (DCTs) market was valued at US$ 7341.6 million in 2023 and is projected to reach US$ 9245.9 million by 2030, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs). This report contains market size and forecasts of Decentralized Clinical Trials (DCTs) in global, including the following market information:
Global Decentralized Clinical Trials (DCTs) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2023 (%)
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
We surveyed the Decentralized Clinical Trials (DCTs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Chapter 1: Introduces the definition of Decentralized Clinical Trials (DCTs), market overview.
Chapter 2: Global Decentralized Clinical Trials (DCTs) market size in revenue.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Decentralized Clinical Trials (DCTs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
